NextPlat (NXPL) Change in Cash (2010 - 2026)
NextPlat's (NXPL) quarterly Change in Cash came in at $932000.0 in Q2 2026, up 184.57% year-over-year from $327507.7 in Q2 2025, and up 134.51% quarter-over-quarter from -$2.7 million in Q1 2026.
Analysis
NextPlat (NXPL) Change in Cash (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Change in Cash for 15 consecutive years, with $932000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Cash rose 184.57% year-over-year to $932000.0 in Q2 2026; TTM through Jun 2026 was -$4.7 million, a 43.04% increase from a year earlier, with the FY2025 full-year figure at -$6.3 million, up 1.51% from the prior year.
- Change in Cash was $932000.0 for Q2 2026 at NextPlat, up from -$2.7 million in the prior quarter.
- Over five years, Change in Cash peaked at $6.4 million in Q4 2022 and troughed at -$8.0 million in Q3 2022.
- A 5-year average of -$296000.0 and a median of -$751000.0 in 2024 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash jumped 4864.95% in 2022 and tumbled 925.64% in 2024, its largest moves.
- Over 5 years, Change in Cash stood at $6.4 million in 2022, then slumped by 100.61% to -$39000.0 in 2023, then plunged by 925.64% to -$400000.0 in 2024, then jumped by 45.75% to -$217000.0 in 2025, then jumped by 529.49% to $932000.0 in 2026.
- The last three Change in Cash figures came in at $932000.0 (Q2 2026), -$2.7 million (Q1 2026), and -$217000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -86.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -915.70 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -44.45 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -64.79 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 526.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 49.04 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 279.95 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 52.68 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 932,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 932,000.00 |
| Mar 31, 2026 | -2.70 Mn |
| Dec 31, 2025 | -217,000.00 |
| Sep 30, 2025 | -2.71 Mn |
| Jun 30, 2025 | -1.10 Mn |
| Mar 31, 2025 | -2.22 Mn |
| Dec 31, 2024 | -400,000.00 |
| Sep 30, 2024 | -4.52 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | -39,000.00 |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 3.89 Mn |
| Mar 31, 2023 | -2.17 Mn |
| Dec 31, 2022 | 6.42 Mn |
| Sep 30, 2022 | -8.00 Mn |
| Jun 30, 2022 | -1.44 Mn |
| Mar 31, 2022 | 4.64 Mn |
| Dec 31, 2021 | 129,334.00 |
| Sep 30, 2021 | 2.72 Mn |